Summary
Moderna's stock plunged 25%, wiping out $18 billion, despite the biotech giant announcing positive trial results for a cancer vaccine, as investors pulled back after an initial surge.
Moderna Stock Plunges 25%, Wiping Out $18 Billion Despite Cancer Vaccine Breakthrough
HyperFast News
Related news
Moderna's 177% Surge Causes $5.5 Billion Loss for Short Sellers
19 Sept 2026, 11:40 pm · News
Moderna co-founder Robert Langer is a billionaire again as stock more than doubles
19 Sept 2026, 11:40 pm · News
Moderna Co-Founder Robert Langer Becomes Billionaire Again as Shares Double
19 Sept 2026, 11:40 pm · News
